PRECISION BIOSCIENCES INC Cash and Restricted Cash
PRECISION BIOSCIENCES INC (DTIL) had Cash and Restricted Cash of $112.41 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-08-06
- 2026-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $112.41M.
- 2026-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $125.85M.
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $137.15M.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $71.21M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
|---|---|
| 2026-06-30 | $112.41M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $125.85M 10-Q · filed 2026-05-05 |
| 2025-12-31 | $137.15M 10-Q · filed 2026-08-06 |
| 2025-09-30 | $71.21M 10-Q · filed 2025-11-03 |
| 2025-06-30 | $84.81M 10-Q · filed 2026-08-06 |
| 2025-03-31 | $99.79M 10-Q · filed 2026-05-05 |
| 2024-12-31 | $108.47M 10-Q · filed 2026-08-06 |
| 2024-09-30 | $121.33M 10-Q · filed 2025-11-03 |
| 2024-06-30 | $123.57M 10-Q · filed 2025-08-07 |
| 2024-03-31 | $137.77M 10-Q · filed 2025-05-15 |
| 2023-12-31 | $116.68M 10-K · filed 2026-03-12 |
| 2023-09-30 | $122.23M 10-Q · filed 2024-11-04 |
| 2023-06-30 | $137.79M 10-Q · filed 2024-08-01 |
| 2023-03-31 | $158.13M 10-Q · filed 2024-05-13 |
| 2022-12-31 | $189.58M 10-K · filed 2025-03-26 |
| 2022-09-30 | $212.05M 10-Q · filed 2023-11-07 |
| 2022-06-30 | $184.13M 10-Q · filed 2023-08-04 |
| 2022-03-31 | $116.22M 10-Q · filed 2023-05-09 |
| 2021-12-31 | $143.66M 10-K · filed 2024-03-27 |
| 2021-09-30 | $160.47M 10-Q · filed 2022-11-08 |
| 2021-06-30 | $173.94M 10-Q · filed 2022-08-08 |
| 2021-03-31 | $193.46M 10-Q · filed 2022-05-09 |
| 2020-12-31 | $89.80M 10-K · filed 2023-03-09 |
| 2020-09-30 | $104.15M 10-Q · filed 2021-11-10 |
| 2020-06-30 | $126.89M 10-Q · filed 2021-08-12 |
| 2020-03-31 | $154.19M 10-Q · filed 2021-05-13 |
| 2019-12-31 | $180.89M 10-K · filed 2022-03-15 |
| 2019-09-30 | $206.26M 10-Q · filed 2020-11-10 |
| 2019-06-30 | $226.10M 10-Q · filed 2020-08-13 |
| 2019-03-31 | $116.50M 10-Q · filed 2020-05-15 |
| 2018-12-31 | $103.19M 10-K · filed 2021-03-18 |
| 2018-09-30 | $127.57M 10-Q · filed 2019-11-12 |
| 2017-12-31 | $62.80M 10-K · filed 2020-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |